Effect of Hippotherapy and Schroth Exercise on Pulmonary Function and Aerobic Capacity in Idiopathic Scoliosis

Scoliosis Idiopathic Clinical Trial

Official title:

Efficacy of Hippotherapy Combined With Schroth Exercises on Pulmonary Function and Aerobic Capacity in Adolescents With Idiopathic Scoliosis: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04833868
• Other study ID #: BMC
• Status: Completed
• Phase: N/A
• Start date: February 20, 2020
• Est. completion date: March 7, 2021

Study information

• Verified date: April 2021
• Source: Batterjee Medical College
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

BACKGROUND: Idiopathic scoliosis has been identified as a common spinal malalignment that negatively impacts the respiratory system and physical conditioning in adolescents. Hippotherapy is an equestrian intervention that optimizes physical performance and mobility in a bunch of contexts; however, its influence on pulmonary function remains unclear. AIM: This research aimed to analyze the impact of ten weeks of hippotherapy combined with Schroth exercises on ventilatory function and aerobic capacity in AIS. DESIGN: Randomized Controlled Trial SETTING: Outpatients attend a single center that includes a rehabilitation room and recreational riding center. POPULATION: Forty-five patients were arbitrarily recruited to the experimental (N= 22) and control group (N=23). METHODS: Patients in the experimental group received 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks. The two groups attended a 60-minute session of Schroth's intervention, 3 times/ week for 10 weeks. Two-way ANOVA for between-group comparisons and independent t-test for within-group comparisons were used in the statistical analysis.

Description:

A total of 45 patients (13 males and 32 females) participated in the current study. The participants were assigned to one of two groups in a random manner: an experimental group who received hippotherapy combined with Schroth Exercise and the control group who received only schorth exercise. (FVC, FEV1, FEV1/FVC, MVV, and 6MWT) were measured before and after 10 weeks intervention

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: March 7, 2021
• Est. primary completion date: December 18, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 18 Years

Eligibility

Inclusion Criteria:

• all types of curves,
• curves between 10 and 20 degrees (29),
• Risser grade 0 to 5
• the availability to be engaged in once a week visit Exclusion Criteria:

Adolescents with:

• obstructive pulmonary diseases
• associated neuromuscular diseases
• recent infectious episodes in the previous two months
• history of cardiovascular or psychological disorders
• any significant history of riding horses

Related Conditions & MeSH terms

• Scoliosis
• Scoliosis Idiopathic

Intervention

Other:
• hippotherapy and schroth exercise
pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week hippotherapy intervention combined with Schroth exercise
• schroth exercise
pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week of Schroth exercise

Locations

Country	Name	City	State
Saudi Arabia	Battarjee Medical College	Jeddah

Sponsors (2)

Lead Sponsor	Collaborator
Batterjee Medical College	Taif University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	FVC in liters	change in FVC measured Using Spiromaster PC-10 Spirometer	ten weeks
Primary	FEV1 in liters	change in FEV1 measured Using Spiromaster PC-10 Spirometer	ten weeks
Primary	MVV in liters/min	change in MVV measured Using Spiromaster PC-10 Spirometer	ten weeks
Primary	FEV1/FVC in percentage	change in FEV1/FVC measured Using Spiromaster PC-10 Spirometer	ten weeks
Primary	aerobic capacity	6MWT	ten weeks